IE43083B1 - Substained-release formulations - Google Patents

Substained-release formulations

Info

Publication number
IE43083B1
IE43083B1 IE508/76A IE50876A IE43083B1 IE 43083 B1 IE43083 B1 IE 43083B1 IE 508/76 A IE508/76 A IE 508/76A IE 50876 A IE50876 A IE 50876A IE 43083 B1 IE43083 B1 IE 43083B1
Authority
IE
Ireland
Prior art keywords
sustained
accordance
release
hydrocolloid
formulation
Prior art date
Application number
IE508/76A
Other languages
English (en)
Other versions
IE43083L (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of IE43083L publication Critical patent/IE43083L/xx
Publication of IE43083B1 publication Critical patent/IE43083B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE508/76A 1975-03-17 1976-03-11 Substained-release formulations IE43083B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (2)

Publication Number Publication Date
IE43083L IE43083L (en) 1976-09-17
IE43083B1 true IE43083B1 (en) 1980-12-17

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
IE508/76A IE43083B1 (en) 1975-03-17 1976-03-11 Substained-release formulations

Country Status (21)

Country Link
JP (1) JPS51115910A (forum.php)
AR (1) AR222624A1 (forum.php)
AT (1) AT353415B (forum.php)
AU (1) AU505355B2 (forum.php)
CA (1) CA1073358A (forum.php)
CH (1) CH630257A5 (forum.php)
DD (1) DD124102A5 (forum.php)
DE (1) DE2611041A1 (forum.php)
DK (1) DK148344C (forum.php)
ES (1) ES446075A1 (forum.php)
FR (1) FR2304354A1 (forum.php)
GB (1) GB1546448A (forum.php)
GR (1) GR60341B (forum.php)
IE (1) IE43083B1 (forum.php)
LU (1) LU74558A1 (forum.php)
MC (1) MC1101A1 (forum.php)
NL (1) NL190313C (forum.php)
NZ (1) NZ180321A (forum.php)
PH (1) PH14927A (forum.php)
PT (1) PT64907B (forum.php)
SE (1) SE433804B (forum.php)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
EP0580861B1 (en) * 1991-04-08 1998-09-09 Nippon Shinyaku Company, Limited Sustained release capsule for adhesion in the gastrointestinal tract
DK0632720T3 (da) * 1992-03-25 1999-07-26 Depomed Inc Hydroxyethylcellulosebaserede depotpræparat-doseringsformer
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
EP0725625B1 (en) * 1993-10-29 2000-03-22 R.P. Scherer Corporation Gelatin capsule fill able to foam
AU8000494A (en) * 1993-10-29 1995-05-22 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
NZ287277A (en) * 1994-05-13 1998-05-27 Smithkline Beecham Corp Oral preparation containing calcium source within a hydrophilic polymer matrix for increasing calcium absorption in the stomach
JPH10509981A (ja) * 1994-12-01 1998-09-29 サイバス ファーマシューティカル，インコーポレイティド 高等植物から得られうる粉末状親水コロイドゴムを用いる持効性薬剤送出
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (forum.php) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
FR2304354A1 (fr) 1976-10-15
IE43083L (en) 1976-09-17
NZ180321A (en) 1978-06-20
LU74558A1 (forum.php) 1977-09-27
ES446075A1 (es) 1977-09-16
FR2304354B1 (forum.php) 1979-04-27
PT64907A (fr) 1976-04-01
MC1101A1 (fr) 1977-02-04
AR222624A1 (es) 1981-06-15
NL190313B (nl) 1993-08-16
AU1204976A (en) 1977-09-22
DE2611041C2 (forum.php) 1988-06-09
DK148344C (da) 1985-11-04
PT64907B (fr) 1978-03-24
DD124102A5 (forum.php) 1977-02-02
JPS638084B2 (forum.php) 1988-02-19
DK148344B (da) 1985-06-17
DK113676A (da) 1976-09-18
NL7602776A (nl) 1976-09-21
GR60341B (en) 1978-05-17
SE7603325L (sv) 1976-09-18
AT353415B (de) 1979-11-12
NL190313C (nl) 1994-01-17
DE2611041A1 (de) 1976-10-14
SE433804B (sv) 1984-06-18
JPS51115910A (en) 1976-10-13
CA1073358A (en) 1980-03-11
CH630257A5 (en) 1982-06-15
GB1546448A (en) 1979-05-23
AU505355B2 (en) 1979-11-15
PH14927A (en) 1982-01-29
ATA192276A (de) 1979-04-15

Similar Documents

Publication Publication Date Title
US4126672A (en) Sustained release pharmaceutical capsules
US4167558A (en) Novel sustained release tablet formulations
US4140755A (en) Sustained release tablet formulations
IE43083B1 (en) Substained-release formulations
US4424235A (en) Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
EP0265061B1 (en) Pharmaceutical formulation
US5232704A (en) Sustained release, bilayer buoyant dosage form
EP0797435B1 (en) Controlled release matrix for pharmaceuticals
JP2509226B2 (ja) ニトロフラントイン投薬型
US3427378A (en) Sustained release encapsulated formula
US4814179A (en) Floating sustained release therapeutic compositions
JPH0830007B2 (ja) 徐放性カプセル
GB2082456A (en) Capsules containing aspirin and alkaline materials
US6080427A (en) Cefadroxil monohydrate tablet formulation
GB2105590A (en) Flotable controlled release preparations
JPH0625064B2 (ja) 制御放出塩化カリウム
US5374430A (en) Pharmaceutical formulation
WO2003015745A1 (en) Expandable gastric retention device
JPH03363B2 (forum.php)
JPS61221116A (ja) 錠剤の組成物
JPH10236959A (ja) 制酸剤含有組成物
Nikam Aaditya et al. A Short Review on Floating Drug Delivery System
NO145261B (no) Fremgangsmaate ved fremstilling av tabletter eller kapsler